Cushing's syndrome: complication of triamcinolone injection for urethral strictures in children.
We report 2 cases of Cushing's syndrome following intralesional triamcinolone acetonide injections of urethral strictures in children. The pharmacology of triamcinolone and its 2 parenteral forms, triamcinolone acetonide and triamcinolone diacetate, is discussed. For children we recommend the short-acting triamcinolone diacetate at 4-week intervals with dosage adjusted to age. In adults either type of triamcinolone may be used but triamcinolone acetonide should be given at 6-week intervals.
D002648:Child; D003480:Cushing Syndrome / Q000139:chemically induced*; D006801:Humans; D007267:Injections; D008297:Male; D014222:Triamcinolone Acetonide / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D014525:Urethral Stricture / Q000188:drug therapy*
D014222:Triamcinolone Acetonide